Skip NavigationSkip to Content

Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFN gamma-Dependent Tumor Vessel Regression

  1. Author:
    Kurebayashi, Yutaka
    Olkowski,Colleen
    Lane, Kelly C.
    Vasalatiy, Olga V.
    Xu, Biying C.
    Okada, Ryuhei
    Furusawa, Aki
    Choyke, Peter L.
    Kobayashi, Hisataka
    Sato, Noriko
  2. Author Address

    NCI, Mol Imaging Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.NCI, Clin Res Directorate, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.NHLBI, Chem & Synth Ctr, NIH, Rockville, MD USA.
    1. Year: 2021
    2. Date: Jun 1
  1. Journal: Cancer Research
  2. AMER ASSOC CANCER RESEARCH,
    1. 81
    2. 11
    3. Pages: 3092-3104
  3. Type of Article: Article
  4. ISSN: 0008-5472
  1. Abstract:

    Regulatory T cells (Tregs) are known to inhibit antitumor immunity, yet the specific mechanism by which intratumoral Tregs promote tumor growth remains unclear. To better understand the roles of intratumoral Tregs, we selectively depleted tumorinfiltrating Tregs using anti-CD25-F(ab') 2 near-infrared photoimmunotherapy. Depletion of tumor-infiltrating Tregs induced transient but synchronized IFN gamma expression in CD8 T and natural killer (NK) cells. Despite the small fraction of CD8 T and NK cells contained within examined tumors, IFN gamma produced by these CD8 T and NK cells led to efficient and rapid tumor vessel regression, intratumoral ischemia, and tumor necrosis/apoptosis and growth suppression. IFN gamma receptor expression on vascular endothelial cells was required for these effects. Similar findings were observed in the early phase of systemic Treg depletion in tumor-bearing Foxp3(DTR) mice; combination with IL15 therapy further inhibited tumor growth and achieved increased complete regression. These results indicate the pivotal roles of intratumoral Tregs in maintaining tumor vessels and tumor growth by suppressing CD8 T and NK cells from producing IFN gamma, providing insight into the mechanism of Treg-targeting therapies.

    See More

External Sources

  1. DOI: 10.1158/0008-5472.CAN-20-2673
  2. PMID: 33574087
  3. PMCID: PMC8178213
  4. WOS: 000659297500026

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel